Skip to content
Review Open access

SLEEP DEPRIVATION AND THE RISK OF STROKE: A SYSTEMATIC REVIEW

Sep 2026 · International journal of medical science and health research · Vol 49, pp. 1010-1027 · 0 citations

TL;DR

Available evidence supports inadequate sleep in duration and quality as a risk marker, and plausibly a modifiable risk factor, for stroke, although definitive causality still requires confirmation through intervention and genetic studies.

Abstract

Background: Stroke is the second and third leading cause of death and disability worldwide, respectively, with a rapidly rising burden in low and middle income countries. Sleep distrubance, wheter inadequate sleep duration, poor sleep quality, insomnia, or obstructive sleep apnea (OSA), has been extensively studied as a potentially modifiable risk factor for stroke. This review summarizes current epidemiological and mechanistic evidence on the relationship between insufficient sleep and stroke risk.   Method: A systematic literature search was conducted across PubMed/MEDLINE, Science Direct, Frontiers, Nature, PMC, and Cochrane Library, using combinations of the terms “sleep duration”, “sleep deprivation”, “insomnia”, “obstructive sleep apnea”, and “stroke risk”, formalized into Boolean stratergy reported in the Method section. Eligible studies comprised meta-analysis and systematic reviews of prospective cohort studies, and randomization studies. Results: Both short (<5-6 h/day) and long (>8-9 h/day) sleep duration were consistently associated with increased stroke risk in prospective cohort studies, with the lowest risk at approximately 7-7,5 h/night. Poor sleep quality, insomnia, and OSA were each independently associated with increased stroke risk, with OSA showing the strongest and most mechanistically consistent effect. However, randomization studies have not consistently demonstrated a causal relationship between sleep duration and stroke risk. Conclusion: Available evidence supports inadequate sleep in duration and quality as a risk marker, and plausibly a modifiable risk factor, for stroke, although definitive causality still requires confirmation through intervention and genetic studies. Screening for sleep disorders, particulary OSA and chronic insomnia, was consider as a part of primary and secondary stroke prevention strategies.

Read PDF

Similar papers

Review Open access Sep 2026

Sleep disorders in stroke rehabilitation: mechanisms, impacts, and multidisciplinary management — a narrative review

Background Sleep disorders and stroke share a bidirectional relationship. Sleep disturbances are independent stroke risk factors and frequent post-stroke complications. Obstructive sleep apnea (OSA), through intermittent hypoxia, systemic inflammation, endothelial dysfunction, and autonomic dysregulation, increases str...

Guo-Jin Hu, Xiu-Li Sun, Cheng Xie · 0 citations
Review Sep 2026

Non-pharmacological interventions for sleep improvement in Alzheimer's disease: A systematic review and meta-analysis

Background Sleep disturbances are common in Alzheimer's disease (AD) and may worsen neuropsychiatric symptoms, caregiver burden, quality of life, and disease progression. Non-pharmacological strategies are increasingly used because long-term hypnotic or antipsychotic treatment may be limited by safety concerns, but the...

Qian-Qian Zhang, Qian Zhou, Meng-Xia Yang et al. · 0 citations
Review Open access Aug 2026

Sleep Disturbance on Stroke Patients: A Narrative Review

Purpose of Review: Sleep disturbance is one of the most prevalent yet systematically neglected consequences of stroke. It affects between one-third and more than half of all stroke survivors, yet it receives a fraction of the clinical attention devoted to motor or cognitive impairment. This review was undertaken to exa...

Sherif A. A. Mohamed, N. Salem, Wael Ibrahim et al. · 0 citations
Review Open access Sep 2026

ROLE OF SLEEP DISORDERS IN TYPE 2 DIABETES MELLITUS - A REVIEW OF CURRENT LITERATURE

Routine sleep screening should be integrated into standard diabetes care, with phenotype-guided treatment of obstructive sleep apnea, insomnia, and restless legs syndrome, and large-scale, long-term randomized trials are needed to determine whether sustained sleep interventions reduce diabetic complications.

Zuzanna Bogdan-Groszyk, Laura Mikuła, Katarzyna Otrębska et al. · 0 citations
#small language model Meta-analysis Open access Sep 2026

Bright light therapy for post-stroke sleep disturbances: a systematic review and meta-analysis

Larger, methodologically rigorous trials using standardized light parameters, standardized outcome measures, and direct circadian assessments are needed to clarify the clinical effects of BLT and identify optimal treatment protocols.

Xiao-Lan Tang, Qiu-Ping Gu, Yang Zhan et al. · 0 citations
Sep 2026

Sleep Apnea and Risk of Comorbid Insomnia in Arab, Black, and White Women and Men; A Longitudinal Study.

STUDY OBJECTIVES Comorbid insomnia and sleep apnea (COMISA) results in worse health outcomes than either condition alone. While the bidirectional link between obstructive sleep apnea (OSA) and insomnia is established, the causal trajectory from OSA to incident insomnia - and potential disparities by sex, race, and ethn...

G. Dunietz, Benjamin Osafo Agyare, Punithavathy Vijayakumar et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.